ABO hemolytic disease: A comparative study of clinical severity and delayed anemia

W. P. Kanto, B. Marino, A. S. Goodwin, Chantrapa Bunyapen

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The hospital and clinic records of 230 neonates with ABO hemolytic disease (HD) were reviewed. There was no significant difference in clinical severity between AO-HD and BO-HD as measured by (1) number of neonates with hyperbilirubinemia and/or those requiring exchange transfusion; (2) hemoglobin concentration; (3) reticulocyte count; (4) bilirubin concentration; and (5) incidence of anemia after discharge from the hospital. There was no difference in the hemoglobin concentrations measured at between four and eight weeks of age in 39 control infants with either AO-HD or BO-HD who did not require an exchange transfusion. Our data do not indicate a clinical difference in the severity of AO-HD and BO-HD. Infants with ABO-HD who do not require exchange transfusion and/or phototherapy and whose hemoglobin concentration at discharge is > 15 gm/dl do not need a hemoglobin measurement before 6 weeks of age.

Original languageEnglish (US)
Pages (from-to)365-369
Number of pages5
JournalPediatrics
Volume62
Issue number3
StatePublished - Dec 1 1978

Fingerprint

Anemia
Hemoglobins
Newborn Infant
Reticulocyte Count
Hyperbilirubinemia
Phototherapy
Clinical Studies
Hospital Records
Bilirubin
Incidence

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Kanto, W. P., Marino, B., Goodwin, A. S., & Bunyapen, C. (1978). ABO hemolytic disease: A comparative study of clinical severity and delayed anemia. Pediatrics, 62(3), 365-369.

ABO hemolytic disease : A comparative study of clinical severity and delayed anemia. / Kanto, W. P.; Marino, B.; Goodwin, A. S.; Bunyapen, Chantrapa.

In: Pediatrics, Vol. 62, No. 3, 01.12.1978, p. 365-369.

Research output: Contribution to journalArticle

Kanto, WP, Marino, B, Goodwin, AS & Bunyapen, C 1978, 'ABO hemolytic disease: A comparative study of clinical severity and delayed anemia', Pediatrics, vol. 62, no. 3, pp. 365-369.
Kanto WP, Marino B, Goodwin AS, Bunyapen C. ABO hemolytic disease: A comparative study of clinical severity and delayed anemia. Pediatrics. 1978 Dec 1;62(3):365-369.
Kanto, W. P. ; Marino, B. ; Goodwin, A. S. ; Bunyapen, Chantrapa. / ABO hemolytic disease : A comparative study of clinical severity and delayed anemia. In: Pediatrics. 1978 ; Vol. 62, No. 3. pp. 365-369.
@article{cb5500e7b2bf48a2abb41cbf14a7f4a3,
title = "ABO hemolytic disease: A comparative study of clinical severity and delayed anemia",
abstract = "The hospital and clinic records of 230 neonates with ABO hemolytic disease (HD) were reviewed. There was no significant difference in clinical severity between AO-HD and BO-HD as measured by (1) number of neonates with hyperbilirubinemia and/or those requiring exchange transfusion; (2) hemoglobin concentration; (3) reticulocyte count; (4) bilirubin concentration; and (5) incidence of anemia after discharge from the hospital. There was no difference in the hemoglobin concentrations measured at between four and eight weeks of age in 39 control infants with either AO-HD or BO-HD who did not require an exchange transfusion. Our data do not indicate a clinical difference in the severity of AO-HD and BO-HD. Infants with ABO-HD who do not require exchange transfusion and/or phototherapy and whose hemoglobin concentration at discharge is > 15 gm/dl do not need a hemoglobin measurement before 6 weeks of age.",
author = "Kanto, {W. P.} and B. Marino and Goodwin, {A. S.} and Chantrapa Bunyapen",
year = "1978",
month = "12",
day = "1",
language = "English (US)",
volume = "62",
pages = "365--369",
journal = "Pediatrics",
issn = "0031-4005",
publisher = "American Academy of Pediatrics",
number = "3",

}

TY - JOUR

T1 - ABO hemolytic disease

T2 - A comparative study of clinical severity and delayed anemia

AU - Kanto, W. P.

AU - Marino, B.

AU - Goodwin, A. S.

AU - Bunyapen, Chantrapa

PY - 1978/12/1

Y1 - 1978/12/1

N2 - The hospital and clinic records of 230 neonates with ABO hemolytic disease (HD) were reviewed. There was no significant difference in clinical severity between AO-HD and BO-HD as measured by (1) number of neonates with hyperbilirubinemia and/or those requiring exchange transfusion; (2) hemoglobin concentration; (3) reticulocyte count; (4) bilirubin concentration; and (5) incidence of anemia after discharge from the hospital. There was no difference in the hemoglobin concentrations measured at between four and eight weeks of age in 39 control infants with either AO-HD or BO-HD who did not require an exchange transfusion. Our data do not indicate a clinical difference in the severity of AO-HD and BO-HD. Infants with ABO-HD who do not require exchange transfusion and/or phototherapy and whose hemoglobin concentration at discharge is > 15 gm/dl do not need a hemoglobin measurement before 6 weeks of age.

AB - The hospital and clinic records of 230 neonates with ABO hemolytic disease (HD) were reviewed. There was no significant difference in clinical severity between AO-HD and BO-HD as measured by (1) number of neonates with hyperbilirubinemia and/or those requiring exchange transfusion; (2) hemoglobin concentration; (3) reticulocyte count; (4) bilirubin concentration; and (5) incidence of anemia after discharge from the hospital. There was no difference in the hemoglobin concentrations measured at between four and eight weeks of age in 39 control infants with either AO-HD or BO-HD who did not require an exchange transfusion. Our data do not indicate a clinical difference in the severity of AO-HD and BO-HD. Infants with ABO-HD who do not require exchange transfusion and/or phototherapy and whose hemoglobin concentration at discharge is > 15 gm/dl do not need a hemoglobin measurement before 6 weeks of age.

UR - http://www.scopus.com/inward/record.url?scp=0018076906&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018076906&partnerID=8YFLogxK

M3 - Article

C2 - 568235

AN - SCOPUS:0018076906

VL - 62

SP - 365

EP - 369

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

IS - 3

ER -